PRNP is a pan-cancer prognostic and immunity-related to EMT in colorectal cancer
PRNP serves as an immune-related prognostic marker that holds promise for predicting outcomes related to CRC immunotherapy while simultaneously promoting cell proliferation, migration, and invasion activities. Furthermore, it potentially plays a role in governing EMT regulation within CRC.
Authors
- Xinghe Liao (ORCID: https://orcid.org/0000-0001-6158-4693)
- Zhiyuan Kong
- Weiping Li
- Haifeng Chen (ORCID: https://orcid.org/0000-0002-4238-7931)
- Yao Du
Institutions
- Shanghai Medical College of Fudan University (CN)
- Nanchang University (CN)
- Soochow University (CN)
- Fudan University Shanghai Cancer Center (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Frontiers in Cell and Developmental Biology
- Published
- 2024-08-05
- DOI
- https://doi.org/10.3389/fcell.2024.1391873
- Citations
- 7
- Primary Topic
- Prion Diseases and Protein Misfolding
- Type
- article
- Field-Weighted Citation Impact
- 1.64
Funders
- Science and Technology Program of Suzhou